Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

ANI PHARMACEUTICALS INC

ANIP · Nasdaq · CIK 0001023024 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

32 Form 4 transaction lines observed in the same window
23 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2022-03-21 · Lalwani Nikhil · $200.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
CAREY STEPHEN P.SVP & CFO
○▼▼○▼▼▼▼
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
▼▼▼○▼▼▼
Lalwani NikhilPRESIDENT & CEO
▼▼▼▼
Thoma JeanneDirector
○▼
Gutwerg OriSVP, GENERICS
▼▼
HAUGHEY THOMASDirector
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-03-21 · Lalwani Nikhil.

Recent Form 4 activity

0Purchases
49Sales
57Other Form 4 lines
76SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING23 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-1.2%
3M
-15.1%
6M
-2.7%
12M
—

Volatility & liquidity

Volatility
31.4%
Beta
0.45
Avg daily value
USD 26.6M

Valuation

Market cap
USD 1.7B
P/E
15.7×

Fundamentals

Profit margin
8.8%
ROE
14.4%
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-03 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,491,281
Previous report
2,490,166
Avg daily volume
487,356
Days to cover
7.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2022-03-21Lalwani NikhilPurchase (P)Common Stock7,224USD 27.69USD 200,033SEC filing ↗
2022-03-21Walsh Patrick DPurchase (P)Common Stock5,000USD 27.76USD 138,800SEC filing ↗
2022-03-21Gassert ChadPurchase (P)Common Stock5,000USD 27.87USD 139,350SEC filing ↗
2022-03-18Gassert ChadPurchase (P)Common Stock5,000USD 27.15USD 135,750SEC filing ↗
2022-03-17Shanmugam MuthusamyPurchase (P)Common Stock5,000USD 27.65USD 138,250SEC filing ↗
2021-12-20Thoma JeannePurchase (P)Common Stock1,072USD 46.47USD 49,816SEC filing ↗
2021-12-07Pera Antonio RPurchase (P)Common Stock3,000USD 42.26USD 126,780SEC filing ↗
2021-12-06HAUGHEY THOMASPurchase (P)Common Stock2,500USD 39.38USD 98,450SEC filing ↗
2021-03-16Thoma JeannePurchase (P)Common Stock1,500USD 33.22USD 49,830SEC filing ↗
2021-03-15Walsh Patrick DPurchase (P)Common Stock4,000USD 32.89USD 131,560SEC filing ↗
2020-11-09Walsh Patrick DPurchase (P)Common Stock5,000USD 25.96USD 129,800SEC filing ↗
2020-08-10Walsh Patrick DPurchase (P)Common Stock10,000USD 30.78USD 307,790SEC filing ↗
2020-03-04HAUGHEY THOMASPurchase (P)Common Stock3,000USD 45.05USD 135,150SEC filing ↗
2020-03-03HAUGHEY THOMASPurchase (P)Common Stock2,000USD 45.18USD 90,360SEC filing ↗

Form 4 evidence

106 transaction lines in the latest 365-day window; 507 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Lalwani NikhilSale (S)Common Stock5,400USD 71.89USD 388,206SEC filing ↗
2026-10-13Cook MeredithSale (S)Common Stock500USD 73.59USD 36,795SEC filing ↗
2026-09-29CAREY STEPHEN P.Sale (S)Common Stock2,850USD 73.00USD 208,050SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Lalwani NikhilSale (S)Common Stock5,400USD 71.89USD 388,206SEC filing ↗
2026-10-13Cook MeredithSale (S)Common Stock500USD 73.59USD 36,795SEC filing ↗
2026-09-29CAREY STEPHEN P.Sale (S)Common Stock2,850USD 73.00USD 208,050SEC filing ↗
2026-09-15Lalwani NikhilSale (S)Common Stock5,400USD 71.00USD 383,400SEC filing ↗
2026-09-14Cook MeredithSale (S)Common Stock500USD 70.79USD 35,395SEC filing ↗
2026-09-11Thoma JeanneSale (S)Common Stock1,000USD 71.53USD 71,530SEC filing ↗
2026-08-31CAREY STEPHEN P.Sale (S)Common Stock2,850USD 72.80USD 207,480SEC filing ↗
2026-08-25Lalwani NikhilSale (S)Common Stock5,400USD 74.30USD 401,220SEC filing ↗
2026-08-19Gosebruch Henry OAward / grant (A)Common Stock6,662USD 0.00USD 0SEC filing ↗
2026-08-13Cook MeredithSale (S)Common Stock500USD 75.48USD 37,740SEC filing ↗
2026-08-10Gutwerg OriSale (S)Common Stock3,162USD 77.00USD 243,474SEC filing ↗
2026-07-29CAREY STEPHEN P.Sale (S)Common Stock2,850USD 81.36USD 231,876SEC filing ↗
2026-07-18Cook MeredithTax withholding (F)Common Stock2,466USD 79.20USD 195,307SEC filing ↗
2026-07-13Cook MeredithSale (S)Common Stock500USD 81.84USD 40,920SEC filing ↗
2026-07-02CAREY STEPHEN P.Sale (S)Common Stock3,313USD 86.00USD 284,918SEC filing ↗
2026-07-02CAREY STEPHEN P.Option exercise / conversion (M)Common Stock3,313USD 49.51USD 164,027SEC filing ↗
2026-06-29CAREY STEPHEN P.Sale (S)Common Stock2,850USD 84.12USD 239,742SEC filing ↗
2026-06-12Cook MeredithSale (S)Common Stock500USD 82.03USD 41,015SEC filing ↗
2026-06-08HAUGHEY THOMASSale (S)Common Stock2,000USD 80.88USD 161,760SEC filing ↗
2026-06-05CAREY STEPHEN P.Sale (S)Common Stock3,312USD 80.00USD 264,960SEC filing ↗
2026-06-05CAREY STEPHEN P.Option exercise / conversion (M)Common Stock3,312USD 49.51USD 163,977SEC filing ↗
2026-05-21Thoma JeanneAward / grant (A)Common Stock4,357USD 0.00USD 0SEC filing ↗
2026-05-21TANNENBAUM RENEE PAward / grant (A)Common Stock4,357USD 0.00USD 0SEC filing ↗
2026-05-21Pera Antonio RAward / grant (A)Common Stock4,357USD 0.00USD 0SEC filing ↗
2026-05-21Leonard Matthew JAward / grant (A)Common Stock4,357USD 0.00USD 0SEC filing ↗
2026-05-21HAUGHEY THOMASAward / grant (A)Common Stock4,357USD 0.00USD 0SEC filing ↗
2026-05-13Walsh Patrick DSale (S)Common Stock10,000USD 80.63USD 806,300SEC filing ↗
2026-05-13Cook MeredithSale (S)Common Stock500USD 78.16USD 39,080SEC filing ↗
2026-05-12Rowland Thomas AndrewSale (S)Common Stock459USD 79.21USD 36,357SEC filing ↗
2026-05-12Gutwerg OriSale (S)Common Stock2,772USD 79.50USD 220,374SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerANIP
CIK0001023024
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history507 transaction lines from 2020-03-03 to 2026-10-15
16 P purchase lines · 201 S sale lines · 290 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.